Press release
Baby healed in world's first gene-editing therapy; Indian-origin doctor plays key role
Genome Editing Therapy Market
Genome editing has transitioned from a theoretical possibility to a transformative therapeutic reality. With tools such as CRISPR-Cas9, TALENs, and zinc finger nucleases (ZFNs), scientists can now make precise modifications to DNA sequences, correcting mutations at their source. This unprecedented capability is paving the way for treatments that cure genetic disorders, rather than just managing symptoms.
The genome editing therapy market is poised for strong growth as pharmaceutical and biotech firms intensify their pipelines, regulatory agencies streamline approval pathways, and investments in precision medicine surge. From rare inherited diseases to cancers and infectious diseases, genome editing therapies are on track to reshape the global healthcare landscape over the next decade.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72646
Market Overview
• The global genome editing therapy market size in 2024 is valued at USD 5.3 billion.
• It is projected to reach USD 23.7 billion by 2034, growing at a CAGR of 16.1 % during the forecast period.
• Growth is driven by increasing R&D activity, expanding clinical trial pipelines, and rising demand for personalized medicine.
Key Market Drivers:
• High prevalence of rare genetic disorders with unmet treatment needs.
• Breakthrough advances in CRISPR and other genome editing platforms.
• Rising venture capital and government funding for gene therapy research.
• Strong partnerships between biotech startups, academia, and pharmaceutical giants.
Key Challenges:
• High therapy costs, often exceeding USD 1 million per patient.
• Ethical and safety concerns related to off-target effects.
• Regulatory complexities across different geographies.
• Scalability issues in manufacturing gene editing therapies.
Leading Players:
Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics, Beam Therapeutics, Caribou Biosciences, Precision BioSciences, Thermo Fisher Scientific, and Horizon Discovery.
Segmentation Analysis
The genome editing therapy market can be segmented as follows:
By Technology
• CRISPR-Cas Systems
• TALENs (Transcription Activator-Like Effector Nucleases)
• Zinc Finger Nucleases (ZFNs)
• Meganucleases
• Others
By Application
• Genetic Disorders (sickle cell disease, cystic fibrosis, muscular dystrophy)
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Ophthalmic Disorders
• Others
By Delivery Method
• Viral Vector-mediated Delivery
• Non-viral Delivery (lipid nanoparticles, electroporation, etc.)
By End-Use
• Hospitals & Clinics
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
Summary:
CRISPR-Cas systems dominate current research and clinical activity due to their simplicity, precision, and cost-effectiveness. Oncology and genetic disorders remain the largest therapeutic areas, while viral vectors are still the leading delivery platform - though non-viral methods are gaining traction for safety and scalability.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72646/genome-editing-therapy-market
Regional Analysis
North America
• Largest market, accounting for nearly 45 % of global revenues in 2024.
• Driven by strong clinical trial activity, FDA support for fast-track approvals, and leadership in CRISPR innovation.
• The U.S. is home to most major genome editing biotech companies.
Europe
• Significant adoption driven by EMA approvals and active research hubs in Germany, France, and the UK.
• Strong focus on rare disease therapies and collaborative academic-industry projects.
Asia-Pacific (APAC)
• Expected to record the fastest CAGR (~18 %) during 2024-2034.
• China leads with aggressive CRISPR research and clinical trials.
• Japan, India, and South Korea are emerging biotech powerhouses in this field.
Middle East & Africa (MEA)
• Early adoption stage, but increasing government support in Gulf nations.
• Limited infrastructure in Africa, though opportunities exist in partnerships for rare disease care.
Latin America
• Brazil and Mexico lead with growing investment in biotechnology and clinical research.
• Expansion of gene therapy-focused trials is expected over the next decade.
Regional Summary:
North America and Europe dominate today, but Asia-Pacific will be the fastest-growing region, playing a pivotal role in scaling genome editing research and commercialization.
Market Dynamics
Growth Drivers
1. Growing approvals of gene-editing-based therapies.
2. Rising prevalence of genetic diseases and cancers.
3. Expanding use of CRISPR and base editing for precision medicine.
4. Increasing partnerships between biotech and pharma for pipeline acceleration.
5. Strong funding inflows from venture capital and government agencies.
Key Challenges
• Ethical concerns about germline editing.
• Managing risks of off-target genetic modifications.
• Cost and accessibility barriers in low- and middle-income countries.
• Regulatory divergence across regions.
Latest Trends
• Base and prime editing emerging as next-gen CRISPR innovations with higher accuracy.
• Ex vivo and in vivo approaches expanding therapeutic reach.
• Use of AI and computational biology to improve target selection and reduce off-target effects.
• Growing integration of genome editing in cell and gene therapy pipelines.
• Development of orphan drug-designated genome editing therapies for rare diseases.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72646
Competitor Analysis
Major Players:
• Editas Medicine
• CRISPR Therapeutics
• Intellia Therapeutics
• Sangamo Therapeutics
• Beam Therapeutics
• Caribou Biosciences
• Precision BioSciences
• Thermo Fisher Scientific
• Horizon Discovery (PerkinElmer subsidiary)
• Bluebird Bio (indirectly via collaborations)
Competitive Summary:
The market is innovation-driven, with biotech startups pioneering advanced CRISPR and base editing technologies, while big pharma invests through partnerships and acquisitions. Companies are racing to expand indications from rare diseases into oncology and infectious diseases. Success will depend on balancing innovation with safety, regulatory compliance, and manufacturing scalability.
Conclusion
The genome editing therapy market is projected to expand from USD 5.3 billion in 2024 to USD 23.7 billion by 2034, at a CAGR of 16.1 %.
This report is also available in the following languages : Japanese (ゲノム編集療法市場), Korean (게놈 편집 치료 시장), Chinese (基因组编辑疗法市场), French (Marché des thérapies par édition génomique), German (Markt für Genomeditierungstherapien), and Italian (Mercato della terapia di editing del genoma), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72646
Our More Reports:
Lipid Nanoparticle Manufacturing Market
https://exactitudeconsultancy.com/reports/72416/lipid-nanoparticle-manufacturing-market
Intravenous Immunoglobulin Market
https://exactitudeconsultancy.com/reports/72414/intravenous-immunoglobulin-market
Veterinary Vaccines Market
https://exactitudeconsultancy.com/reports/72412/veterinary-vaccines-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Baby healed in world's first gene-editing therapy; Indian-origin doctor plays key role here
News-ID: 4202117 • Views: …
More Releases from Exactitude Consultancy
A New Study Verifies Insulin Nasal Spray's Ability to Deliver Alzheimer's Drug S …
Introduction
Drug delivery innovation has been a driving force in enhancing patient outcomes, improving compliance, and maximizing therapeutic efficiency. Among non-invasive routes, nasal drug delivery has gained exceptional prominence due to its ability to deliver systemic, local, and even central nervous system (CNS)-targeted therapies without needles. The nasal route bypasses the gastrointestinal tract and first-pass metabolism, enabling faster onset of action and improved bioavailability for a wide range of pharmaceuticals.
From allergy…
RION Works with Lonza to Expand the Production and Development of Exosomes
The global Exosomes Development and Manufacturing Market is emerging as a critical enabler of regenerative medicine, oncology, neurology, and advanced drug delivery systems. Exosomes-nanosized extracellular vesicles secreted by cells-play a pivotal role in intercellular communication, carrying proteins, lipids, and nucleic acids that influence cellular functions. Their unique biological properties are being harnessed for therapeutics, diagnostics, and targeted drug delivery, making exosomes one of the most promising frontiers in biotechnology.
Download Full…
A Novel Approach to Molecular Cancer Imaging Technologies: Aptamers
The global Aptamers Market is gaining strong momentum as biotechnology and pharmaceutical companies increasingly leverage aptamers for drug discovery, diagnostics, targeted therapeutics, and biomarker research. Aptamers are short, single-stranded DNA, RNA, or peptide molecules that bind with high specificity and affinity to a wide range of targets, from proteins to small molecules and even entire cells. Often compared to antibodies, aptamers offer several advantages-chemical stability, lower production cost, ease of…
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased …
Introduction
Flow cytometry has become a cornerstone technology in modern biomedical research and clinical diagnostics. By enabling rapid, quantitative, and multiparametric analysis of single cells in suspension, flow cytometry has transformed fields such as immunology, oncology, stem cell biology, and infectious disease research. The technique supports critical applications like immunophenotyping, cell sorting, biomarker detection, and drug discovery.
As the demand for high-throughput cell-based analysis grows, flow cytometry services are increasingly sought by…
More Releases for CRISPR
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
CRISPR and CRISPR-Associated (Cas) Genes Market 2021 | Detailed Report
The CRISPR and CRISPR-Associated (Cas) Genes research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about…
